<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"	
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Psychiatry &amp; Mental Health &#187; The Doctor&#039;s Channel</title>
	<atom:link href="http://www.thedoctorschannel.com/channels/psychiatry/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedoctorschannel.com</link>
	<description>Internet TV for Doctors</description>
	<lastBuildDate>Wed, 16 May 2012 23:34:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
			<item>
		<title>Chronic benzodiazepine use risky in adults with schizophrenia</title>
		<link>http://www.thedoctorschannel.com/view/chronic-benzodiazepine-use-risky-in-adults-with-schizophrenia/</link>
		<pubDate>Thu, 10 May 2012 21:02:38 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Psychiatry & Mental Health]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[antipsychotic]]></category>
		<category><![CDATA[benzodiazepine]]></category>
		<category><![CDATA[Schizophrenia]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31613</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – In patients with schizophrenia, chronic use of benzodiazepines is associated with an increased risk of death, whereas treatment with an antidepressant or several concomitant antipsychotics is not, according to a Finnish study published this week. Long-term use of benzodiazepines among patients with schizophrenia is common in Finland, the United States -]]></description>
		
			<media:content duration="1:44" medium="video">
		<media:title><![CDATA[Chronic benzodiazepine use risky in adults with schizophrenia]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – In patients with schizophrenia, chronic use of benzodiazepines is associated with an increased risk of death, whereas treatment with an antidepressant or several concomitant antipsychotics is not, according to a Finnish study published this week. Long-term use of benzodiazepines among patients with schizophrenia is common in Finland, the United States -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/chronic-benzodiazepine-use-risky-in-adults-with-schizophrenia/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120510clin001.jpg"/>
	<media:keywords><![CDATA[antidepressant,antipsychotic,benzodiazepine,Schizophrenia]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Human Genome Sequencing</title>
		<link>http://www.thedoctorschannel.com/view/human-genome-sequencing/</link>
		<pubDate>Fri, 24 Feb 2012 23:10:13 +0000</pubDate> 
				<category><![CDATA[Psychiatry & Mental Health]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[FGS]]></category>
		<category><![CDATA[genetics]]></category>
		<category><![CDATA[genome sequence]]></category>
		<category><![CDATA[genome sequencing]]></category>
		<category><![CDATA[human genome]]></category>
		<category><![CDATA[Robert L. Klitzman]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=25579</guid>
		<description><![CDATA[Robert Klitzman, M.D., Professor of Clinical Psychiatry at the Columbia University Medical Center, discusses the advantages and disadvantages of full genome sequencing. With new advances and breakthroughs in the field, important questions arise about the ramifications of human genome sequencing in family planning, in the pricing structure of healthcare policies, in the workplace, and in -]]></description>
		
			<media:content duration="2:12" medium="video">
		<media:title><![CDATA[Human Genome Sequencing]]></media:title>
	<media:description><![CDATA[Robert Klitzman, M.D., Professor of Clinical Psychiatry at the Columbia University Medical Center, discusses the advantages and disadvantages of full genome sequencing. With new advances and breakthroughs in the field, important questions arise about the ramifications of human genome sequencing in family planning, in the pricing structure of healthcare policies, in the workplace, and in -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/human-genome-sequencing/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/02/Picture-16.png"/>
	<media:keywords><![CDATA[DNA,FGS,genetics,genome sequence,genome sequencing,human genome,Robert L. Klitzman]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Some antipsychotics better than others for young people: review</title>
		<link>http://www.thedoctorschannel.com/view/some-antipsychotics-better-than-others-for-young-people-review/</link>
		<pubDate>Fri, 24 Feb 2012 20:20:36 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Psychiatry & Mental Health]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[antipsychotic]]></category>
		<category><![CDATA[antipsychotics]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[olanzapine]]></category>
		<category><![CDATA[quetiapine]]></category>
		<category><![CDATA[risperdal]]></category>
		<category><![CDATA[risperidone]]></category>
		<category><![CDATA[seroquel]]></category>
		<category><![CDATA[Zyprexa]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=25565</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Despite widespread use of antipsychotics in children, evidence regarding the comparative benefits and harms of first-generation (FGAs) and second-generation antipsychotics (SGAs) are “limited,” conclude the authors of a review published February 20 in Pediatrics. The analysis does show that some SGAs have a better side effect profile that others, first -]]></description>
		
			<media:content duration="01:42" medium="video">
		<media:title><![CDATA[Some antipsychotics better than others for young people: review]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Despite widespread use of antipsychotics in children, evidence regarding the comparative benefits and harms of first-generation (FGAs) and second-generation antipsychotics (SGAs) are “limited,” conclude the authors of a review published February 20 in Pediatrics. The analysis does show that some SGAs have a better side effect profile that others, first -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/some-antipsychotics-better-than-others-for-young-people-review/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/02/Thumbnail_20120224clin001.jpg"/>
	<media:keywords><![CDATA[antipsychotic,antipsychotics,children,olanzapine,quetiapine,risperdal,risperidone,seroquel,Zyprexa]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>NSAIDs might help curb schizophrenia</title>
		<link>http://www.thedoctorschannel.com/view/nsaids-might-help-curb-schizophrenia/</link>
		<pubDate>Thu, 19 Jan 2012 00:09:51 +0000</pubDate> 
				<category><![CDATA[Psychiatry & Mental Health]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[antipsychotic]]></category>
		<category><![CDATA[aspirin]]></category>
		<category><![CDATA[celecoxib]]></category>
		<category><![CDATA[NSAIDs]]></category>
		<category><![CDATA[Schizophrenia]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=23260</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Pooled data suggest that nonsteroidal anti-inflammatory drugs (NSAIDs) can augment antipsychotic treatment and reduce schizophrenia symptom severity, Dutch researchers report in a December 13th on-line paper in the Journal of Clinical Psychiatry. &#8220;We found that NSAIDs used in addition to antipsychotics can ameliorate both psychotic and negative symptoms, which is -]]></description>
		
			<media:content duration="1:36" medium="video">
		<media:title><![CDATA[NSAIDs might help curb schizophrenia]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Pooled data suggest that nonsteroidal anti-inflammatory drugs (NSAIDs) can augment antipsychotic treatment and reduce schizophrenia symptom severity, Dutch researchers report in a December 13th on-line paper in the Journal of Clinical Psychiatry. &#8220;We found that NSAIDs used in addition to antipsychotics can ameliorate both psychotic and negative symptoms, which is -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/nsaids-might-help-curb-schizophrenia/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/01/Screen-shot-2012-01-18-at-7.08.41-PM.png"/>
	<media:keywords><![CDATA[antipsychotic,aspirin,celecoxib,NSAIDs,Schizophrenia]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Prevalence of prediabetes high in patients on antipsychotics</title>
		<link>http://www.thedoctorschannel.com/view/prevalence-of-prediabetes-high-in-patients-on-antipsychotics/</link>
		<pubDate>Tue, 17 Jan 2012 21:25:18 +0000</pubDate> 
				<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Psychiatry & Mental Health]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[antipsychotic]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[insulin resistance]]></category>
		<category><![CDATA[Prediabetes]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=23163</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Based on the 2010 American Diabetes Association’s definition of prediabetes, the condition is present in over a third of psychiatric inpatients treated with antipsychotic drugs, according to a report in the Journal of Clinical Psychiatry online December 27. “The excess in body mass index and abdominal distribution of adiposity found -]]></description>
		
			<media:content duration="1:35" medium="video">
		<media:title><![CDATA[Prevalence of prediabetes high in patients on antipsychotics]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Based on the 2010 American Diabetes Association’s definition of prediabetes, the condition is present in over a third of psychiatric inpatients treated with antipsychotic drugs, according to a report in the Journal of Clinical Psychiatry online December 27. “The excess in body mass index and abdominal distribution of adiposity found -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/prevalence-of-prediabetes-high-in-patients-on-antipsychotics/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/01/Screen-shot-2012-01-17-at-4.26.48-PM.png"/>
	<media:keywords><![CDATA[antipsychotic,diabetes,insulin resistance,Prediabetes]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Risperidone effective for bipolar I disorder in children; side effects a concern</title>
		<link>http://www.thedoctorschannel.com/view/risperidone-effective-for-bipolar-i-disorder-in-children-side-effects-a-concern/</link>
		<pubDate>Fri, 06 Jan 2012 17:55:33 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Psychiatry & Mental Health]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[divalproate]]></category>
		<category><![CDATA[hyperprolactinemia]]></category>
		<category><![CDATA[risperidone]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=22786</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – More children with bipolar I disorder (manic or mixed phase) respond to the antipsychotic risperidone than to lithium or the anticonvulsant divalproex sodium, a multicenter team reports in the Archives of General Psychiatry online January 2. However, risperidone “is associated with adverse effects such as weight gain and hyperprolactinemia that -]]></description>
		
			<media:content duration="1:51" medium="video">
		<media:title><![CDATA[Risperidone effective for bipolar I disorder in children; side effects a concern]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – More children with bipolar I disorder (manic or mixed phase) respond to the antipsychotic risperidone than to lithium or the anticonvulsant divalproex sodium, a multicenter team reports in the Archives of General Psychiatry online January 2. However, risperidone “is associated with adverse effects such as weight gain and hyperprolactinemia that -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/risperidone-effective-for-bipolar-i-disorder-in-children-side-effects-a-concern/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/01/Screen-shot-2012-01-06-at-11.52.28-AM.png"/>
	<media:keywords><![CDATA[bipolar disorder,divalproate,hyperprolactinemia,risperidone]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Immediate medical treatment best nonsurgical approach to early miscarriage</title>
		<link>http://www.thedoctorschannel.com/view/immediate-medical-treatment-best-nonsurgical-approach-to-early-miscarriage/</link>
		<pubDate>Mon, 02 Jan 2012 17:29:02 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Psychiatry & Mental Health]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[addiction]]></category>
		<category><![CDATA[methamphetamine]]></category>
		<category><![CDATA[topamax]]></category>
		<category><![CDATA[topiramate]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=22663</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – For the nonsurgical management of first-trimester miscarriage, delayed medical treatment (i.e., monitoring for expulsion followed, if needed, by mifepristone and/or misoprostol) “may not be a reasonable option,” clinicians from France conclude based on a study they conducted. They found that delaying medical treatment for first trimester miscarriage increases the likelihood -]]></description>
		
			<media:content duration="1:42" medium="video">
		<media:title><![CDATA[Immediate medical treatment best nonsurgical approach to early miscarriage]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – For the nonsurgical management of first-trimester miscarriage, delayed medical treatment (i.e., monitoring for expulsion followed, if needed, by mifepristone and/or misoprostol) “may not be a reasonable option,” clinicians from France conclude based on a study they conducted. They found that delaying medical treatment for first trimester miscarriage increases the likelihood -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/immediate-medical-treatment-best-nonsurgical-approach-to-early-miscarriage/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/01/Screen-shot-2012-01-03-at-11.58.14-AM.png"/>
	<media:keywords><![CDATA[addiction,methamphetamine,topamax,topiramate]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Topiramate may help former methamphetamine addicts from relapsing</title>
		<link>http://www.thedoctorschannel.com/view/topiramate-may-help-former-methamphetamine-addicts-from-relapsing/</link>
		<pubDate>Mon, 02 Jan 2012 17:12:25 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Psychiatry & Mental Health]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[addiction]]></category>
		<category><![CDATA[methamphetamine]]></category>
		<category><![CDATA[topamax]]></category>
		<category><![CDATA[topiramate]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=22651</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – In methamphetamine-dependent adults, treatment with the anticonvulsant topiramate (Topamax; Ortho-McNeil Neurologics) does little to promote abstinence, but it seems to help those on the road to abstinence, according to a study accepted for publication in the journal Addiction. Research has shown that topiramate attenuates downstream midbrain dopamine release, which might -]]></description>
		
			<media:content duration="1:25" medium="video">
		<media:title><![CDATA[Topiramate may help former methamphetamine addicts from relapsing]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – In methamphetamine-dependent adults, treatment with the anticonvulsant topiramate (Topamax; Ortho-McNeil Neurologics) does little to promote abstinence, but it seems to help those on the road to abstinence, according to a study accepted for publication in the journal Addiction. Research has shown that topiramate attenuates downstream midbrain dopamine release, which might -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/topiramate-may-help-former-methamphetamine-addicts-from-relapsing/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/01/Screen-shot-2012-01-03-at-11.22.35-AM.png"/>
	<media:keywords><![CDATA[addiction,methamphetamine,topamax,topiramate]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Aripiprazole may be effective as maintenance for some children with bipolar disorder</title>
		<link>http://www.thedoctorschannel.com/view/aripiprazole-may-be-effective-as-maintenance-for-some-children-with-bipolar-disorder-2/</link>
		<pubDate>Fri, 16 Dec 2011 13:32:00 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Psychiatry & Mental Health]]></category>
		<category><![CDATA[Resource Center: Bipolar Disorder]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[aripiprazole]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[family medicine]]></category>
		<category><![CDATA[pediatrics]]></category>
		<guid isPermaLink="false">http://new.thedoctorschannel.com/view/aripiprazole-may-be-effective-as-maintenance-for-some-children-with-bipolar-disorder-2/</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – After stabilization with aripiprazole therapy, children with bipolar disorder may continue to benefit from maintenance treatment with the atypical antidepressant, according to the results of a double-blind, placebo-controlled trial reported in the Journal of Clinical Psychiatry online November 29. However, the authors note, “Even though aripiprazole maintenance was statistically superior -]]></description>
		
			<media:content duration="1:29" medium="video">
		<media:title><![CDATA[Aripiprazole may be effective as maintenance for some children with bipolar disorder]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – After stabilization with aripiprazole therapy, children with bipolar disorder may continue to benefit from maintenance treatment with the atypical antidepressant, according to the results of a double-blind, placebo-controlled trial reported in the Journal of Clinical Psychiatry online November 29. However, the authors note, “Even though aripiprazole maintenance was statistically superior -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/aripiprazole-may-be-effective-as-maintenance-for-some-children-with-bipolar-disorder-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2011/12/4937.jpg"/>
	<media:keywords><![CDATA[aripiprazole,bipolar disorder,family medicine,Nurses/NP/PA,pediatrics,Psychiatry &amp; Mental Health]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Buprenorphine/naloxone helpful in prescription opioid dependence</title>
		<link>http://www.thedoctorschannel.com/view/buprenorphinenaloxone-helpful-in-prescription-opioid-dependence/</link>
		<pubDate>Fri, 18 Nov 2011 04:18:00 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Pain Management]]></category>
		<category><![CDATA[Psychiatry & Mental Health]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Buprenorphine/naloxone]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[opioid]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Reuters]]></category>
		<guid isPermaLink="false">http://new.thedoctorschannel.com/view/buprenorphinenaloxone-helpful-in-prescription-opioid-dependence/</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Buprenorphine-naloxone (Suboxone, Reckitt-Benckiser) helps curb prescription opioid dependence, but counseling does little to boost success rates, according to results of a randomized controlled trial published online today in Archives of General Psychiatry. The study found that opioid-dependent patients, with or without chronic pain, are likely to reduce their opioid use -]]></description>
		
			<media:content duration="1:51" medium="video">
		<media:title><![CDATA[Buprenorphine/naloxone helpful in prescription opioid dependence]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Buprenorphine-naloxone (Suboxone, Reckitt-Benckiser) helps curb prescription opioid dependence, but counseling does little to boost success rates, according to results of a randomized controlled trial published online today in Archives of General Psychiatry. The study found that opioid-dependent patients, with or without chronic pain, are likely to reduce their opioid use -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/buprenorphinenaloxone-helpful-in-prescription-opioid-dependence/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2011/12/4828.jpg"/>
	<media:keywords><![CDATA[Buprenorphine/naloxone,News,opioid,pain,Reuters]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
	</channel>
</rss>
